U.S. Paper and Forestry Products Stock News

If you are wondering whether Everpure is still good value at around US$67.72, you are not alone. The answer depends heavily on how you look at its valuation. The stock has seen mixed returns, with a 6.8% decline over the last 7 days and a 2.9% decline over the past month, set against a 10.5% return over 1 year, 137.3% over 3 years and 192.0% over 5 years. Recent coverage has focused on Everpure's long term share price performance and how it compares to broader tech names. This has reminded...

VEON Ltd. recently signed a Memorandum of Understanding with Hala, Dubai's leading e-hailing taxi solution backed by the RTA and Careem, to explore joint expansion of ride-hailing and mobility services across VEON's operating markets. This collaboration could deepen VEON's digital ecosystem by pairing its frontier-market reach with Hala's ride-hailing expertise, potentially broadening use cases beyond core telecom services. We’ll now examine how VEON’s move to expand ride-hailing...

Mitsui Sumitomo Insurance Co., LTD, a ten-percent owner of W. R. Berkley (NYSE:WRB), recently made substantial share purchases. The transactions were carried out in February 2026 through a pre arranged trading plan. The increased insider stake highlights fresh activity by a major shareholder that has not yet been widely discussed. W. R. Berkley operates as a commercial lines insurer, so this is a business tied closely to underwriting discipline, capital strength and risk management. Large...

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...

Getty Realty (GTY) is back in the spotlight after completing a follow on equity offering of 4,000,000 common shares at US$32.48 per share, raising about US$129.92 million in conjunction with related forward sale agreements. See our latest analysis for Getty Realty. The follow on offering comes after a run of solid reported results and a strong share price trend. Getty Realty’s 30 day share price return of 11.95% and year to date share price return of 18.32% sit alongside a 5 year total...

If you are wondering whether Tandem Diabetes Care at around US$26.90 is starting to look mispriced, you are not alone. The numbers give us plenty to unpack. The stock has seen sharp recent moves, with a 42.8% return over the last 7 days and 35.2% over the last 30 days. This is even though the 1 year return sits at a 19.3% decline and the 5 year return at a 71.2% decline. Recent news coverage has focused on Tandem Diabetes Care's position in diabetes technology and product updates that keep...

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...

Constellation Energy (CEG) has wrapped up FY 2025 with Q4 revenue of US$6.1b, Basic EPS of US$1.38 and net income of US$432m, putting a concrete set of numbers behind the recent share price of US$312.64. The company has seen quarterly revenue range between US$6.1b and US$6.8b across FY 2025, while Basic EPS moved from US$0.38 in Q1 to US$2.97 in Q3 before landing at US$1.38 in Q4, giving investors a clear view of how profit per share has shifted through the year. With trailing 12 month net...

Terex stock performance at a glance Terex (TEX) has drawn fresh attention after a strong recent run, with the share price showing a 15.5% gain over the past month and a 50.4% return over the past 3 months. For investors tracking longer horizons, Terex shows a 65.4% total return over the past year and 70.5% over five years, alongside annual revenue of US$5.4b and net income of US$221.0m. See our latest analysis for Terex. With the share price at US$68.85, Terex has moved from a softer 7 day...

Deckers Outdoor recently reported Q3 2026 results that beat analyst expectations, with revenue rising year over year and full-year guidance reaffirmed. This performance, alongside upbeat analyst commentary on the resilience of UGG and HOKA and the company’s margin profile, has reinforced confidence in Deckers’ business momentum. Now we’ll examine how this earnings beat and renewed analyst confidence might reshape Deckers Outdoor’s existing investment narrative. We've uncovered the 16...

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...

If you are wondering whether York Space Systems at around US$27.95 is offering good value today, this article walks through what the numbers actually say about the stock. The share price has been relatively steady over the past week with a 0.2% decline, but year to date the stock is down 16.8%. This may change how you think about its risk and potential. Recent coverage has focused on York Space Systems as a listed space infrastructure player, highlighting investor interest in satellite...

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

Hertz Global Holdings (HTZ) has been on many investors’ watchlists after a mixed share price pattern, with a roughly 20% decline over the past month but a modest gain over the past year. See our latest analysis for Hertz Global Holdings. With the latest share price at $4.44, Hertz Global Holdings has seen momentum fade recently, with a 30-day share price return of 19.71% and a year-to-date share price return of 14.94%, even though the 1-year total shareholder return is 4.72% and the 3-year...

If you are wondering whether Live Nation Entertainment's current share price lines up with its underlying value, you are not alone. Many investors are asking the same question right now. The stock last closed at US$157.98, with returns of 0.3% over the past week, 7.5% over the past month, 8.7% year to date and 9.4% over the past year, so it is understandable that investors want to know what is priced in. Recent headlines around Live Nation have continued to focus on the broader live events...

The CEO and a board director of Watts Water Technologies (NYSE:WTS) recently reported insider share sales within a short time frame. The company also disclosed several acquisitions focused on water management and control solutions. Management is committing capital to smart, connected product lines as part of its broader digital transformation efforts. Watts Water Technologies, traded on the NYSE under the ticker WTS, focuses on products that control the flow, safety, and quality of water in...

If you are wondering whether Woodward's current share price reflects its real worth, you are not alone. This article is built to help you frame that question clearly. Woodward's share price recently closed at US$394.76, with returns of 2.0% over 7 days, 20.7% over 30 days, 27.0% year to date, 116.8% over 1 year, 305.8% over 3 years and 247.4% over 5 years. This naturally raises questions about what is already priced in and what might still be at stake. Against this backdrop, the key story...

Progress Software recently reported strong quarterly results, underpinned by recurring revenue from its subscription model, high‑margin infrastructure software, and the ahead‑of‑schedule integration of its largest acquisition, ShareFile. The addition of Nuclia’s agentic RAG technology and continued customer reliance on Progress’s mission‑critical products highlight how AI and acquisitions are becoming central to its business model. Next, we’ll explore how Progress Software’s early completion...

OSI Systems, Inc. recently announced that its Security division’s Itemiser 4DX and new Itemiser 5X trace detection systems achieved ECAC/EU G1 approval, meeting the highest current European standards for aviation security and enabling use across airports, cargo screening, and other critical security settings. This certification strengthens OSI Systems’ position in regulated security markets by aligning its widely deployed trace detection platforms with the strictest European compliance...

If you are wondering whether Primo Brands at around US$19.36 is a bargain or a value trap, you are not alone. This article is designed to help you frame that question clearly. The stock has seen mixed returns, with a 5.9% move over the last 7 days, 0.5% over 30 days, 19.6% year to date, a 41.6% decline over 1 year, and gains of 36.6% and 48.2% over 3 and 5 years respectively. These figures can change how investors think about both upside and risk. Recent news coverage around Primo Brands has...

If you are wondering whether Teleflex is starting to look like value after a tough few years, this article will walk through what the current share price might be implying. The stock has risen 5.9% over the last 7 days and 8.4% over the last 30 days, although it remains down 8.4% year to date and 36.2% over 1 year, with a 51.8% 3 year and 71.3% 5 year decline. Recent coverage of Teleflex has largely focused on how the share price has pulled back over several years and what that means for...

If you are wondering whether Eli Lilly's current share price fairly reflects its long term potential, you are not alone. This article is designed to help you make sense of what you are paying for. The stock last closed at US$1,042.15, with returns of 0.6% over 7 days, a 2.1% decline over 30 days, a 3.5% decline year to date, and a 16.4% gain over the past year. The 3 year return sits at 242.4% and the 5 year return at 436.6%. Recent headlines around Eli Lilly have focused on its role in...

Oncolytics Biotech (ONCY) has attracted fresh attention after a recent move in its share price, with the stock closing at US$1.13 and showing mixed return patterns across the past year and over multiple years. See our latest analysis for Oncolytics Biotech. The recent 6.6% 1 day share price return and 10.8% 7 day share price return suggest short term momentum is building around Oncolytics Biotech, even as the 58.3% 1 year total shareholder return contrasts with weaker 3 and 5 year total...

New global tariffs announced by the Trump administration and weaker recent financial updates have put Crocs (CROX) in focus, as investors reconsider the stock in light of softer guidance and pressure on internationally reliant supply chains. See our latest analysis for Crocs. The mixed backdrop of tariff headlines, softer guidance and ongoing buybacks has coincided with a 12.65% 1 month share price return and 13.14% 3 month share price return. However, the 1 year total shareholder return of...